4//SEC Filing
Tregoning Kathleen 4
Accession 0000899243-23-004364
CIK 0001805387other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 8:30 PM ET
Size
12.9 KB
Accession
0000899243-23-004364
Insider Transaction Report
Form 4
Tregoning Kathleen
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-02-06+54,320→ 54,320 totalExercise: $34.41Exp: 2033-02-06→ Common Stock (54,320 underlying) - Award
Restricted Stock Units
2023-02-06+13,804→ 13,804 total→ Common Stock (13,804 underlying)
Footnotes (3)
- [F1]25% of this option shall vest and become exercisable on February 6, 2024, with the remainder vesting in thirty-six (36) monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F2]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock.
- [F3]The RSUs vest in four equal annual installments on each of February 6, 2024, February 6, 2025, February 6, 2026 and February 6, 2027, subject to the Reporting Person's continued service on each such vesting date.
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001830764
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 8:30 PM ET
- Size
- 12.9 KB